Thomas A. McCourt
2015
In 2015, Thomas A. McCourt earned a total compensation of $1.6M as Senior Vice President, Marketing and Sales and Chief Commercial Officer at Ironwood Pharmaceuticals, a 55% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $243,600 |
|---|---|
| Option Awards | $693,293 |
| Salary | $420,000 |
| Stock Awards | $253,825 |
| Other | $7,440 |
| Total | $1,618,158 |
McCourt received $693.3K in option awards, accounting for 43% of the total pay in 2015.
McCourt also received $243.6K in non-equity incentive plan, $420K in salary, $253.8K in stock awards and $7.4K in other compensation.
Rankings
In 2015, Thomas A. McCourt's compensation ranked 5,610th out of 13,638 executives tracked by ExecPay. In other words, McCourt earned more than 58.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,610 out of 13,638 | 59th |
Division Manufacturing | 2,079 out of 5,190 | 60th |
Major group Chemicals And Allied Products | 750 out of 1,854 | 60th |
Industry group Drugs | 595 out of 1,528 | 61st |
Industry Pharmaceutical Preparations | 467 out of 1,182 | 61st |
Source: SEC filing on April 15, 2016.
McCourt's colleagues
We found four more compensation records of executives who worked with Thomas A. McCourt at Ironwood Pharmaceuticals in 2015.
News
Ironwood Pharmaceuticals CEO Thomas McCourt's 2021 pay jumps 158% to $8.8M
April 21, 2022
Ironwood Pharmaceuticals CEO Mark Mallon's 2020 pay falls 32% to $6.8M
April 22, 2021
Ironwood Pharmaceuticals CEO Mark Mallon receives $10M in 2019
April 21, 2020
Ironwood Pharmaceuticals CEO Peter Hecht's 2018 pay slips 14% to $5.2M
April 26, 2019